Ann: Shareholder Newsletter, page-41

Andrew ... it was late at night and my back it or cash in comment was not appropriate ... I apologise for that. Note that it was not levelled specifically at you but more about the ongoing debate about the CN. It's happened and we have to deal with it. The criticism of the CN was valid and timely 18 months ago but we often revert back to it not just as an aside but as a re-invigorated debate. This has been an excellent forum over a long period of time with great views on the science and commercial aspects of the company - both positive and negative and including your contributions. However, it is at it's best when the debate is about current matters and looking forward to where the next scientific or commercial direction may move. That's exciting - I'm just a little over the CN debate.

All the best.
Timbo